CS68891A2 - Antihypercholesterolaemia - Google Patents

Antihypercholesterolaemia Download PDF

Info

Publication number
CS68891A2
CS68891A2 CS91688A CS68891A CS68891A2 CS 68891 A2 CS68891 A2 CS 68891A2 CS 91688 A CS91688 A CS 91688A CS 68891 A CS68891 A CS 68891A CS 68891 A2 CS68891 A2 CS 68891A2
Authority
CS
Czechoslovakia
Prior art keywords
compound
formula
culture
compounds
group
Prior art date
Application number
CS91688A
Other languages
Czech (cs)
English (en)
Inventor
James D Bergstrom
Otto D Hensens
Leeyuan Huang
Janet C Onishi
Deborah L Zink
Gerald F Bills
Mary Nallin
Kenneth F Bartizal
James A Milligan
Walter Rozdilsky
Claude Dufresne
Maria T Diez
Original Assignee
Merck O Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/496,734 external-priority patent/US5132320A/en
Priority claimed from US07/625,572 external-priority patent/US5055487A/en
Application filed by Merck O Co filed Critical Merck O Co
Publication of CS68891A2 publication Critical patent/CS68891A2/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/90—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14—Fungi; Culture media therefor
    • C12N1/145—Fungal isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/181—Heterocyclic compounds containing oxygen atoms as the only ring heteroatoms in the condensed system, e.g. Salinomycin, Septamycin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/645—Fungi ; Processes using fungi

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Environmental Sciences (AREA)
  • Obesity (AREA)
  • Plant Pathology (AREA)
  • Dentistry (AREA)
  • Hematology (AREA)
  • Agronomy & Crop Science (AREA)
  • Diabetes (AREA)
  • Pest Control & Pesticides (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
CS91688A 1990-03-21 1991-03-15 Antihypercholesterolaemia CS68891A2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US49674390A 1990-03-21 1990-03-21
US49673390A 1990-03-21 1990-03-21
US07/496,734 US5132320A (en) 1990-03-21 1990-03-21 Squalene synthetase inhibitors
US07/625,572 US5055487A (en) 1990-03-21 1990-12-11 Novel anti-fungal compounds

Publications (1)

Publication Number Publication Date
CS68891A2 true CS68891A2 (en) 1991-11-12

Family

ID=27504382

Family Applications (1)

Application Number Title Priority Date Filing Date
CS91688A CS68891A2 (en) 1990-03-21 1991-03-15 Antihypercholesterolaemia

Country Status (14)

Country Link
EP (1) EP0448393A1 (sh)
JP (1) JPH04217986A (sh)
KR (1) KR910016915A (sh)
AU (1) AU640756B2 (sh)
CA (1) CA2038450A1 (sh)
CS (1) CS68891A2 (sh)
FI (1) FI911352A (sh)
HU (1) HUT61554A (sh)
IE (1) IE910935A1 (sh)
IL (1) IL97251A0 (sh)
NO (1) NO911122L (sh)
NZ (1) NZ237405A (sh)
PT (1) PT97068A (sh)
YU (1) YU48791A (sh)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL97535A0 (en) * 1990-03-21 1992-06-21 Merck & Co Inc Squalene synthetase inhibitor dioxabicyclo(1,2,3)octanes,their production and pharmaceutical compositions containing them
NZ239663A (en) * 1990-09-13 1993-07-27 Merck & Co Inc Ester derivatives of dioxabicyclo(3,2,1)-octane, medicaments, and a fungus which makes them
GB9100437D0 (en) * 1991-01-09 1991-02-20 Glaxo Group Ltd Chemical compounds
MX9202156A (es) * 1991-05-10 1993-08-01 Merck & Co Inc Novedosos compuestos para reducir el colesterol.
US5256689A (en) * 1991-05-10 1993-10-26 Merck & Co., Inc. Cholesterol lowering compounds
CA2071655A1 (en) * 1991-06-28 1992-12-29 Gerald F. Bills Sporormiella intermedia and processes therefrom
GB2261375A (en) * 1991-11-15 1993-05-19 Merck & Co Inc Inhibitors of farnesyl protein transferase as anti-cancer agents
US5294627A (en) * 1992-08-27 1994-03-15 Merck & Co., Inc. Directed biosynthesis of biologically active compounds
US5252471A (en) * 1992-03-09 1993-10-12 Merck & Co., Inc. Directed biosynthesis of cholesterol lowering compounds
GB9205136D0 (en) * 1992-03-10 1992-04-22 Glaxo Group Ltd Chemical compounds
GB9205140D0 (en) * 1992-03-10 1992-04-22 Glaxo Group Ltd Chemical compounds
EP0568946A1 (en) * 1992-05-08 1993-11-10 Takeda Chemical Industries, Ltd. Compound TAN-1607A, its derivatives, their production, and use thereof
US5283256A (en) * 1992-07-22 1994-02-01 Merck & Co., Inc. Cholesterol-lowering agents
US5322855A (en) * 1992-10-19 1994-06-21 Merck & Co., Inc. Cholesterol lowering compounds
US5332728A (en) * 1992-11-23 1994-07-26 Bristol-Myers Squibb Company Method for treating a fungal infection
US5447717A (en) * 1993-02-25 1995-09-05 Merck & Co., Inc. Cholesterol-lowering agents
WO1995004025A1 (fr) * 1993-07-29 1995-02-09 Chugai Seiyaku Kabushiki Kaisha Derive d'acide tricarboxylique a activite d'inhibition de la squalene-synthetase
US5783593A (en) * 1993-11-04 1998-07-21 Abbott Laboratories Inhibitors of squalene synthetase and protein farnesyltransferase
US5631401A (en) * 1994-02-09 1997-05-20 Abbott Laboratories Inhibitors of protein farnesyltransferase and squalene synthase
US5430055A (en) * 1994-04-08 1995-07-04 Pfizer Inc. Inhibitor of squalene synthase

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4871721A (en) * 1988-01-11 1989-10-03 E. R. Squibb & Sons, Inc. Phosphorus-containing squalene synthetase inhibitors
IL97535A0 (en) * 1990-03-21 1992-06-21 Merck & Co Inc Squalene synthetase inhibitor dioxabicyclo(1,2,3)octanes,their production and pharmaceutical compositions containing them
NZ239663A (en) * 1990-09-13 1993-07-27 Merck & Co Inc Ester derivatives of dioxabicyclo(3,2,1)-octane, medicaments, and a fungus which makes them

Also Published As

Publication number Publication date
JPH04217986A (ja) 1992-08-07
IL97251A0 (en) 1992-05-25
IE910935A1 (en) 1991-09-25
HUT61554A (en) 1993-01-28
YU48791A (sh) 1994-01-20
KR910016915A (ko) 1991-11-05
FI911352A (fi) 1991-09-22
AU7370491A (en) 1991-10-03
EP0448393A1 (en) 1991-09-25
NZ237405A (en) 1993-07-27
NO911122L (no) 1991-09-23
AU640756B2 (en) 1993-09-02
PT97068A (pt) 1991-11-29
NO911122D0 (no) 1991-03-20
HU910929D0 (en) 1991-10-28
CA2038450A1 (en) 1991-09-22
FI911352A0 (fi) 1991-03-20

Similar Documents

Publication Publication Date Title
CS68891A2 (en) Antihypercholesterolaemia
KR100333017B1 (ko) 폴리사이클릭구충제,이의제조방법,이의제조용균주및이를포함하는조성물
US5055487A (en) Novel anti-fungal compounds
US5026554A (en) Method of inhibiting fungal growth using squalene synthetase inhibitors
US5053425A (en) Novel anti-fungal compounds
AU640755B2 (en) 2,8-dioxabicyclo(3,2,1)octane derivatives and culture of MF5453 for their production and use as antihypercholesterolemics
US5096923A (en) Novel squalene synthetase inhibitors
US5132320A (en) Squalene synthetase inhibitors
EP0475706A1 (en) Novel squalene synthetase inhibitors
AU603271B2 (en) Derivatives of paraherquamide isolated from a fermentation broth active as antiparasitic agents
EP0478061A1 (en) Antiviral agent
US5164389A (en) Anthelmintic bioconversion products
US5801172A (en) Antifungal agent from sporomiella minimoides
GB2261375A (en) Inhibitors of farnesyl protein transferase as anti-cancer agents
WO1994008940A1 (en) Acyclic tricarboxylic acid compounds
US5441987A (en) Antifungal agent
GB2265147A (en) Antibiotic eicosenoic acids
US5702929A (en) Antifungal agent
US5686637A (en) Antifungal agent
EP0525846A1 (en) Sporomiella intermedia and processes therefrom
CA2701606A1 (en) Antifungal agents
GB2306480A (en) Antifungal agents
GB2306474A (en) Antifungal agent
JP2008263855A (ja) ノルゾアンタミンの生産方法
JP2008266204A (ja) ノルゾアンタミンの生産方法とその利用